Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 19 35 years 2. Newly diagnosed PCOS 3. Stage II and III Periodontitis patients 4. Systemically healthy women for control groups
Exclusion criteria
Exclusion criteria: 1. Patients with medical conditions causing hyperandrogenism (e.g., androgen-secreting tumors, congenital adrenal hyperplasia, Cushing s syndrome). 2. Patients with significant systemic illnesses such as thyroid disorders, hyperprolactinemia, hypertension, diabetes, cardiovascular, hepatic or renal diseases, chronic inflammatory diseases, malignancy, pregnancy, immunodeficiency; smokers and alcohol users. 3. Individuals who received periodontal treatment in the past 6 months. 4. Individuals using medications that can influence periodontal status or PCOS in the last 6 months (e.g., oral contraceptives, steroids/hormonal therapy, antipsychotics, antiepileptics, antihypertensives, insulin-sensitizing drugs, antibiotics, anti-inflammatory drugs).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Salivary Periostin Levels measured using ELISA -Salivary Leptin Levels measured using ELISATimepoint: -Salivary Periostin Levels measured using ELISA -Salivary Leptin Levels measured using ELISA | — |
Secondary
| Measure | Time frame |
|---|---|
| Periodontal Clinical Parameters PI, GI, BOP, PD, CALTimepoint: At baseline | — |
Countries
India
Contacts
AB SHETTY MEMORIAL INSTITUTE OF DENTAL SCIENCES